-
Subject Areas on Research
-
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.
-
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
-
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
-
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.
-
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.
-
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.
-
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.
-
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.
-
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.
-
25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density.
-
A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis.
-
A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis.
-
A novel high-performance liquid chromatography/mass spectrometry method for improved selective and sensitive measurement of methotrexate polyglutamation status in human red blood cells.
-
A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities.
-
Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases.
-
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
-
Adiposity in Juvenile Psoriatic Arthritis.
-
Adverse Childhood Experiences Are Associated with Childhood-Onset Arthritis in a National Sample of US Youth: An Analysis of the 2016 National Survey of Children's Health.
-
An i2b2-based, generalizable, open source, self-scaling chronic disease registry.
-
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.
-
Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
-
Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists.
-
Association of Transition Readiness to Intentional Self-Regulation and Hopeful Future Expectations in Youth With Illness.
-
Association of the CCR5 gene with juvenile idiopathic arthritis.
-
Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis.
-
Autoantibodies to DEK oncoprotein in human inflammatory disease.
-
Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry.
-
Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
-
Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry.
-
Blau syndrome and related genetic disorders causing childhood arthritis.
-
Bone metabolism in childhood rheumatic disease.
-
Bone mineral status in juvenile rheumatoid arthritis.
-
Breast feeding and the development of juvenile rheumatoid arthritis.
-
Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis.
-
CARRA: The Childhood Arthritis and Rheumatology Research Alliance.
-
Cardiovascular Health in Pediatric Rheumatologic Diseases.
-
Causes of pain in children with arthritis.
-
Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis.
-
Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis.
-
Clinical Features and Treatment of Down Syndrome Arthropathy: Experience from Two US Tertiary Hospitals.
-
Clinical Trial Design in Juvenile Idiopathic Arthritis.
-
Clinical trials in pediatric rheumatology: comment on the editorial by Lehman.
-
Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.
-
Colonic Diverticulitis in a 19-Year-Old Boy With Juvenile Idiopathic Arthritis: Surgical Implications of Chronic Immunosuppression.
-
Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis.
-
Complete response to steroids in dural inflammatory pseudotumor associated with Still's disease.
-
Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients.
-
Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.
-
DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.
-
DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.
-
Daily pain and symptoms in children with polyarticular arthritis.
-
Daily sleep quality and mood as predictors of pain in children with juvenile polyarticular arthritis.
-
Decreased expression of nicotinamide phosphoribosyltransferase in patients with juvenile idiopathic arthritis receiving methotrexate.
-
Decreased use of non-steroidal anti-inflammatory drugs for the treatment of juvenile idiopathic arthritis in the era of modern aggressive treatment.
-
Development of biomarkers to optimize pediatric patient management: what makes children different?
-
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
-
Down Syndrome-Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes.
-
Effectiveness and toxicity of methotrexate in juvenile idiopathic arthritis: comparison of 2 initial dosing regimens.
-
Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis.
-
Emotion regulation predicts pain and functioning in children with juvenile idiopathic arthritis: an electronic diary study.
-
Engaging patients and parents to improve mental health intervention for youth with rheumatological disease.
-
Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry.
-
Enthesitis-related arthritis: time to re-define?
-
Epistasis amongst PTPN2 and genes of the vitamin D pathway contributes to risk of juvenile idiopathic arthritis.
-
Evidence for linkage of HLA loci in juvenile idiopathic oligoarthritis: independent effects of HLA-A and HLA-DRB1.
-
Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritis.
-
Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study.
-
Familial autoimmunity in the Childhood Arthritis and Rheumatology Research Alliance registry.
-
Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases.
-
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
-
Folate depletion and increased glutamation in juvenile idiopathic arthritis patients treated with methotrexate.
-
Frequency of abnormal hand and wrist radiographs at time of diagnosis of polyarticular juvenile rheumatoid arthritis.
-
Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
-
Genome-Wide Association Meta-Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility Loci.
-
Goniotomy for glaucoma secondary to chronic childhood uveitis.
-
Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis.
-
Hepatoxicity with encephalopathy associated with aspirin therapy in rheumatoid arthritis.
-
Hierarchy of risk of childhood-onset rheumatoid arthritis conferred by HLA-DRB1 alleles encoding the shared epitope.
-
Hodgkin's lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis.
-
Identification of a novel susceptibility locus for juvenile idiopathic arthritis by genome-wide association analysis.
-
Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosus.
-
If patients are the true north, patient-centeredness should guide research.
-
Impact of the Season of Birth on the Development of Juvenile Idiopathic Arthritis in the United States: A Nationwide Registry-based Study.
-
Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study.
-
Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis.
-
Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized Scleroderma.
-
Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15.
-
Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry.
-
Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap.
-
Juvenile arthritis and autoimmunity to type II collagen.
-
Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study.
-
Juvenile idiopathic arthritis.
-
Juvenile rheumatoid arthritis in velo-cardio-facial syndrome: coincidence or unusual complication?
-
Juvenile rheumatoid arthritis: benefits from massage therapy.
-
Lack of association between juvenile idiopathic arthritis and fas gene polymorphism.
-
Linkage and association studies of discoidin domain receptor 1 (DDR1) single nucleotide polymorphisms (SNPs) in juvenile oligoarthritis.
-
Linkage and association studies of single-nucleotide polymorphism-tagged tumor necrosis factor haplotypes in juvenile oligoarthritis.
-
Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
-
Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis.
-
Massive calcification of the mitral annulus in a 17-year-old patient with juvenile rheumatoid arthritis and systemic lupus erythematosis.
-
Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.
-
Methotrexate: new uses for an old drug.
-
Monoclonal antibodies that detect biochemical markers of arthritis in humans.
-
Multisite Randomized Clinical Trial Evaluating an Online Self-Management Program for Adolescents With Juvenile Idiopathic Arthritis.
-
Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis.
-
Neuroendocrine gene polymorphisms and susceptibility to juvenile idiopathic arthritis.
-
New Medications Are Needed for Children With Juvenile Idiopathic Arthritis.
-
Niacin-like reaction to infliximab infusion in systemic juvenile rheumatoid arthritis.
-
Nicotinamide Phosphoribosyltransferase Attenuates Methotrexate Response in Juvenile Idiopathic Arthritis and In Vitro.
-
Nomenclature and classification in chronic childhood arthritis: time for a change?
-
Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project.
-
Ophthalmologic examinations in children with juvenile rheumatoid arthritis.
-
Opioid therapy for the treatment of refractory pain in children with juvenile rheumatoid arthritis.
-
Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
-
Pain as a quality of care measure in juvenile idiopathic arthritis: one step forward, but is it the best foot? Comment on the article by Lovell et al.
-
Pain coping and the pain experience in children with juvenile chronic arthritis.
-
Pain in children with arthritis: a review of the current literature.
-
Pain, stiffness, and fatigue in juvenile polyarticular arthritis: contemporaneous stressful events and mood as predictors.
-
Parent pain responses as predictors of daily activities and mood in children with juvenile idiopathic arthritis: the utility of electronic diaries.
-
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
-
Pediatric Rheumatology Comes of Age: Part I.
-
Pediatric Rheumatology Comes of Age: Part II.
-
Pediatric pain syndromes and management of pain in children and adolescents with rheumatic disease.
-
Peer rejection, social behavior, and psychological adjustment in children with juvenile rheumatic disease.
-
Periprosthetic fracture between a constrained total knee arthroplasty and a long-stem total hip arthroplasty: treatment with a novel device.
-
Pilot Study of the Juvenile Dermatomyositis Consensus Treatment Plans: A CARRA Registry Study.
-
Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
-
Positive association of SLC26A2 gene polymorphisms with susceptibility to systemic-onset juvenile idiopathic arthritis.
-
Predictors of changes in disease activity among children with juvenile dermatomyositis enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry.
-
Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis.
-
Prescribing for Children With Rheumatic Disease: Perceived Treatment Approaches Between Pediatric and Adult Rheumatologists.
-
Prescription patterns for children with juvenile idiopathic arthritis in Michigan Medicaid: a comparison by prescriber type.
-
Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids.
-
Profile of adalimumab and its potential in the treatment of uveitis.
-
Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept.
-
Prominent expression of mRNA for proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis.
-
Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood.
-
Prospective Mediation Models of Sleep, Pain, and Daily Function in Children With Arthritis Using Ecological Momentary Assessment.
-
Psychometric characteristics of outcome measures in juvenile idiopathic arthritis: a systematic review.
-
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.
-
Radiographic progression in children with polyarticular juvenile rheumatoid arthritis: a pilot study.
-
Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis.
-
Red blood cell folate concentrations and polyglutamate distribution in juvenile arthritis: predictors of folate variability.
-
Repair of osteopenia in children with juvenile rheumatoid arthritis.
-
Retroperitoneal fibrosis in children.
-
Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources.
-
Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis.
-
Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results.
-
Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study.
-
Sleep quality in children with juvenile rheumatoid arthritis.
-
Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis.
-
Social functioning and facial expression recognition in survivors of pediatric brain tumors.
-
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study.
-
Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis.
-
T Cell Receptor-Independent, CD31/IL-17A-Driven Inflammatory Axis Shapes Synovitis in Juvenile Idiopathic Arthritis.
-
The DEK nuclear autoantigen is a secreted chemotactic factor.
-
The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.
-
The association of PTPN22 rs2476601 with juvenile idiopathic arthritis is specific to females.
-
The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response.
-
The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.
-
The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus.
-
The relationship of daily mood and stressful events to symptoms in juvenile rheumatic disease.
-
The school experience of children with arthritis. Coping in the 1990s and transition into adulthood.
-
Therapeutic advancements in juvenile idiopathic arthritis.
-
Total hip arthroplasty in juvenile rheumatoid arthritis. Two to eleven-year results.
-
Toward Accelerated Authorization and Access to New Medicines for Juvenile Idiopathic Arthritis.
-
Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.
-
Translating research into practice-implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retreat.
-
Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey.
-
Treatment of juvenile idiopathic arthritis-associated uveitis: challenges and update.
-
Treatment of pain in juvenile idiopathic arthritis: a survey of pediatric rheumatologists.
-
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
-
Tumor necrosis factor blockers in rheumatoid arthritis.
-
Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis.
-
Ultrasound versus magnetic resonance imaging of the temporomandibular joint in juvenile idiopathic arthritis: a systematic review.
-
Update in juvenile rheumatoid arthritis.
-
Use of tumor necrosis factor inhibitors in uveitis.
-
Uveitis in children.
-
Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility.